Save information for later
Sign Up

Learn About Bowen's Disease

What is the definition of Bowen's Disease?
A form of squamous cell carcinoma in situ. It is a distinct clinicopathological entity and arises from the skin or the mucocutaneous junction. It affects predominantly white males in their 6-8th decades of life. Exposed and non-exposed skin sites are equally affected. UV damage and ingestion of inorganic arsenic may play a role in the development of the disease. On the skin surface, it presents as a single or multiple erythematous, scaly, keratotic patches or plaques. The clinical entity of erythroplasia of Queyrat is regarded as Bowen disease of the penis and it presents as an asymptomatic, red, circumscribed plaque. Morphologically, Bowen disease is characterized by the presence of hyperkeratosis, parakeratosis, dyskeratosis, and acanthosis. The keratotic squamous cells are atypical and display hyperchromatism and abnormal mitotic figures. The dermoepidermal basement membrane is intact. Complete surgical removal of the lesion may be curative.
What are the alternative names for Bowen's Disease?
  • Bowen's disease
Who are the top Bowen's Disease Local Doctors?

Kansas Medical Clinic PA

11301 Nall Ave, Suite 205, 
Leawood, KS 
 (4.3 mi)
Languages Spoken:
English
Accepting New Patients

Kyle Anderson is a Dermatologist in Leawood, Kansas. Dr. Anderson and is rated as an Advanced provider by MediFind in the treatment of Bowen's Disease. His top areas of expertise are Lamellar Ichthyosis, Syringocystadenoma Papilliferum, Syringoma, and Sebaceous Adenoma. Dr. Anderson is currently accepting new patients.

Dermatology
Dermatology

Kansas City Skin And Cancer Center LLC

9301 W 74th St, Suite 230, 
Shawnee Mission, KS 
 (1.5 mi)
Languages Spoken:
English, Mandarin
Accepting New Patients

Wenfei Xie is a Dermatologist in Shawnee Mission, Kansas. Dr. Xie and is rated as an Experienced provider by MediFind in the treatment of Bowen's Disease. Her top areas of expertise are Neurocutaneous Melanosis, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus. Dr. Xie is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Nurse Practitioner | Dermatology
Nurse Practitioner | Dermatology

Kansas Medical Clinic PA

5820 Lamar Ave, Suite 200, 
Mission, KS 
 (2.9 mi)
Languages Spoken:
English
Accepting New Patients

Teresa Corrigan is a Nurse Practitioner specialist and a Dermatologist in Mission, Kansas. Corrigan and is rated as an Experienced provider by MediFind in the treatment of Bowen's Disease. Her top areas of expertise are Actinic Keratosis, Sunburn, Warts, and Seborrheic Keratosis. Corrigan is currently accepting new patients.

What are the latest Bowen's Disease Clinical Trials?
Evaluation of the Clinical Utility of a New Diagnostic Support Tool, Based on Electrical Impedance Spectroscopy (NEVISENSE), for Keratinocyte Skin Cancer

Summary: This is a prospective study to assess efficacy of the Nevisense device in identifying keratinocyte skin cancer (KC) in patients suspected of having skin cancer based on the initial physician's assessment. All skin lesions with a suspicion of Basal cell carcinoma (BCC), Invasive Squamos cell Carcinoma (iSCC), Bowen's disease (BD) or actinic keratosis (AK) and destined for excision or biopsy for fur...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease: a Multicenter Randomized Controlled Trial

Objective: The aim of this study is 1) to evaluate the (cost)effectiveness of 5FU and PDT compared to SE in BD and 2) to compare the effectiveness of 5FU with that of PDT. With a better understanding of the (cost)effectiveness of alternative treatment options, the investigators will supply the necessary evidence for national and international guidelines, to achieve more uniformity in treatment of BD. Study d...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center